 |
|
|
| |
Early post liver transplant rescue treatment with
sofosbuvir/velpatasvir/voxilaprevir in
patients experienced to NS5A-inhibitors
|
| |
| |
EASL 2022 June 22-26 London
EASL: Multicenter prospective study for the use of shortened pre-emptive therapy with Glecaprevir/Pibrentasvir (G/P) and Ezetimibe in hepatitis C (HCV) seronegative non-liver solid organ transplant recipients of HCV viremic grafts - (07/02/22)
Margherita Saracco1, Francesco Tandoi2, Francesca Maletta3, Alberto Calleri1, Donatella Cocchis2, Giorgia Rizza2, Renato Romagnoli2, Silvia Martini1
1Gastrohepatology Unit, 2Liver Transplantation Centre and General Surgery 2U, 3Pathology Unit
AOU Citta della Salute e della Scienza di Torino, Turin, Italy
|
| |
|
|
|
|
|
